FdaApplication
NDA 006317
Identifiers
- fda_app_no: NDA006317
Properties
| Property | Value |
|---|---|
| applicant_name | ELI LILLY AND CO |
| application_type | NDA |
Products (3)
| Product | Active ingredient | Strength | Dosage form |
|---|---|---|---|
| NEOTRIZINE | TRISULFAPYRIMIDINES (SULFADIAZINE; SULFAMERAZINE; SULFAMETHAZINE) | 167MG;167MG;167MG | TABLET;ORAL |
| NEOTRIZINE | TRISULFAPYRIMIDINES (SULFADIAZINE; SULFAMERAZINE; SULFAMETHAZINE) | 167MG/5ML;167MG/5ML;167MG/5ML | SUSPENSION;ORAL |
| SULFONAMIDES DUPLEX | SULFADIAZINE; SULFAMERAZINE | 250MG/5ML;250MG/5ML | SUSPENSION;ORAL |
3 products